Profile data is unavailable for this security.
About the company
Uniphar PLC is an Ireland-based diversified healthcare service company. The Company is focused on improving access to pharmaco-medical products and therapies. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through its on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare and animal health products to pharmacies, hospitals and veterinary surgeons in Ireland. It operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. It also provides services and support that help independent community pharmacies.
- Revenue in EUR (TTM)2.55bn
- Net income in EUR44.82m
- Incorporated1994
- Employees3.26k
- LocationUniphar PLC4045 Kingswood DriveCitywest Business ParkDUBLIN D24 VO6KIrelandIRL
- Phone+353 14287777
- Fax+353 14287776
- Websitehttps://www.uniphar.ie/
Mergers & acquisitions
| Acquired company | UPR:ISE since announced | Transaction value |
|---|---|---|
| Sam Mccauley (Bunclody) Chemists Ltd | -21.98% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adcock Ingram Holdings Limited | 450.06m | 42.79m | 438.14m | 2.39k | 10.11 | 1.53 | -- | 0.9735 | 5.49 | 5.49 | 57.72 | 36.26 | 1.12 | 2.52 | 4.38 | -- | 10.68 | 10.50 | 14.81 | 14.90 | 34.32 | 32.38 | 9.51 | 9.34 | 0.9352 | -- | 0.0806 | 40.35 | 4.89 | 7.43 | 12.25 | 7.45 | -7.92 | 7.77 |
| Shanghai New World Co Ltd | 145.96m | 4.08m | 494.65m | 1.20k | 121.40 | 0.9197 | -- | 3.39 | 0.0489 | 0.0489 | 1.75 | 6.46 | 0.1989 | 4.04 | 9.34 | 942,475.30 | 0.5521 | 0.5242 | 0.7459 | 0.7249 | 37.63 | 33.70 | 2.78 | 2.71 | 1.44 | -- | 0.1252 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| Nu Skin Enterprises, Inc. | 1.84bn | 8.01m | 566.56m | 3.70k | 75.47 | 0.7371 | 7.64 | 0.3087 | 0.1622 | 0.1622 | 38.97 | 16.61 | 1.09 | 1.95 | 32.75 | 532,197.60 | 0.4739 | 6.80 | 0.5848 | 8.90 | 68.93 | 73.45 | 0.4365 | 5.26 | 1.28 | -- | 0.3797 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
| YSB Inc | 2.18bn | -410.40m | 605.09m | 6.31k | -- | 2.45 | -- | 0.277 | -25.65 | -25.65 | 47.51 | 3.24 | -- | -- | -- | 2,908,964.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
| Uniphar PLC | 2.55bn | 44.82m | 685.27m | 3.26k | 15.29 | 2.06 | 8.51 | 0.2684 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
| NanJing Pharmaceutical Co Ltd | 6.90bn | 74.38m | 796.12m | 4.90k | 10.74 | 0.9479 | -- | 0.1154 | 0.4397 | 0.4397 | 40.75 | 4.98 | 1.78 | 8.70 | 4.11 | 10,929,970.00 | 2.37 | 2.32 | 8.06 | 8.94 | 5.98 | 6.41 | 1.33 | 1.30 | 1.09 | 2.91 | 0.6148 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Herbalife Ltd | 4.72bn | 132.53m | 825.86m | 9.20k | 6.25 | -- | 3.47 | 0.175 | 1.42 | 1.42 | 50.51 | -10.69 | 1.83 | 2.19 | 66.70 | 550,260.90 | 5.13 | 11.30 | 8.65 | 18.70 | 76.47 | 78.43 | 2.81 | 6.02 | 0.6998 | 2.92 | 1.71 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
| Neuca SA | 2.74bn | 33.90m | 916.76m | 5.19k | 27.61 | 3.98 | 14.43 | 0.3349 | 32.42 | 32.42 | 2,617.05 | 224.63 | 2.38 | 7.47 | 7.13 | 2,276,477.00 | 3.21 | 3.58 | 12.45 | 13.31 | 11.07 | 10.33 | 1.35 | 1.43 | 0.4725 | 4.33 | 0.3336 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Allianz Global Investors GmbHas of 02 Feb 2024 | 32.86m | 12.04% |
| Polar Capital LLPas of 02 May 2023 | 20.13m | 7.37% |
| Mackenzie Financial Corp.as of 22 Feb 2023 | 17.37m | 6.36% |
| Mackenzie Investments Europe Ltd.as of 30 Sep 2023 | 10.46m | 3.83% |
| Swedbank Robur Fonder ABas of 29 Feb 2024 | 9.96m | 3.65% |
| Amundi Asset Management SA (Investment Management)as of 03 Apr 2024 | 5.67m | 2.08% |
| Danske Bank A/S (Investment Management)as of 31 Mar 2024 | 5.11m | 1.87% |
| Allianz Global Investors GmbH (France)as of 31 Dec 2023 | 5.10m | 1.87% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Dec 2022 | 3.86m | 1.41% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2024 | 3.30m | 1.21% |
